Pharmaceutical Bioprocessing Technologies primarily concentrates on the development, enhancement, and comprehension of biomaterials for medical applications, including antibacterial and biomarking purposes. Additionally, it encompasses the molecular design of engineered proteins as potential drug or vaccine candidates. In accordance with contemporary trends, the field will also explore tissue engineering and regenerative medicine for the treatment of degenerated organs or cells.
Dr. Ana Masara Ahmad Mokhtar
Degree: BSc (Universiti Putra Malaysia), Ph.D (University of Cambridge); Expertise: Biochemistry; Cell culture; Small G-protein; Cancer; Molecular Biology
Dr. Liong Min Tze
Degree: BTech, M.Sc (USM), Ph.D (Australia); Expertise: Probiotics and/or prebiotics as food adjuncts; Functionality and bioactivity of synbiotics via animals/humans trials; Health potential of probiotics via fermentation of agricultural wastes
Dr. Mohamad Hafizi Abu Bakar
Degree: B.Sc. (IIUM), Ph.D. (UTM); Expertise: Cell-based technology; cellular agriculture; metabolic signalling; tissue crosstalk; cultivated meat.
Dr. Nor Hawani Salikin
Degree: B.Sc (Universiti Sains Malaysia), M.Sc (Universiti Sains Malaysia), Ph.D (University of New South Wales, Sydney); Expertise: Discovery of bioactive compound from marine microorganisms (i.e., antinematode metabolite); Enzyme production through fermentation (SSF); Microbiology; Molecular Biology